2Lyn Patrick ND. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress[J]. Altern Med Rev,2002,7 (4) :276 -291. 被引量：1
3Day CP. Steatohepatitis: a tale of two “hits”? [J]. Gastroenterology 1998,114:842-845. 被引量：1
4Giulio Marchesini, Mara Brizi, Giampaolo Bianchi, et al. Nonalcoholic Fatty Liver Disease A Feature of the Metabolic Syndrome[J]. Diabetes,2001,50:1844-1850. 被引量：1
5Marchesini G, Brizi M, Antonio M, et al. Association of non- alcoholic fatty liver disease to insulin resistance[ J]. Am J Med, 1999,107: 450 -455. 被引量：1
6Prasad V G Katakam, Michael R Ujhelyi, Margarethe Hoenig, et al.Metformin Improves Vascular Function in Insulin- Resistant Rats [ J].Hypertension,2000,35:108-112. 被引量：1
7Stith BJ, Woronoff K, Wiernsperger N. Stimulation of the intracellular portion of the human insulin receptor by the antidiabetic drug metformin[J]. Biochemical Pharmacology, 1998,55:533-536. 被引量：1
8Meuillet EJ, Wiernsperger N, Mania- Farnell B, et al. Metformin modulates insulin receptor signaling in normal and cholesterol-treated human hepatoma cells (HepG2) [ J]. European Journal of Pharmacology, 1999,377: 241-252. 被引量：1
9Lin HZ, Yang SQ, Chuckaree C, et al. Metformin reverses fatty liver disease in obese, leptin deficient mice [ J ]. Nat Med, 2000, 6: 998 -1003. 被引量：1
10Giulio Marchesini,Mara Brizi, Giampaolo Bianchi, et al. Metformin in non-alcoholic steatohepatitis[ J]. Lancet, 2001,358: 893 - 894. 被引量：1
